alexa Role of Male Factor Testing in Recurrent Pregnancy Loss or In Vitro Fertilization Failure | OMICS International
ISSN: 2161-038X
Reproductive System & Sexual Disorders: Current Research

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Role of Male Factor Testing in Recurrent Pregnancy Loss or In Vitro Fertilization Failure

Ryan Dickey1 and Ranjith Ramasamy2*

1Department of Urology, Baylor College of Medicine, Houston, Texas, USA

2Department of Urology, University of Miami – Miller School of Medicine, Miami, Florida, USA

*Corresponding Author:
Ramasamy R
1120 NW 14th Street
CRB 1560, Miami, FL 33136, USA
Tel: 305 243 4562
E-mail: [email protected]

Received date: August 11, 2015 Accepted date:August 11, 2015 Published date: August 19, 2015

Citation: Dickey R and Ramasamy R(2015) Role of Male Factor Testing in Recurrent Pregnancy Loss or In Vitro Fertilization Failure . Reprod Syst Sex Disord 4:e122. doi: 10.4172/2161-038X.1000e122

Copyright: © 2015 Ramasamy R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Reproductive System & Sexual Disorders: Current Research

Editorial

The appropriate management for male partners of couples with recurrent pregnancy loss (RPL) or recurrent implantation failure during in vitro fertilization (IVF) remains unclear. In particular, men with normal semen parameters are often ignored because the “bulk semen parameters” appear normal [1]. Despite normal semen parameters, male partners in couples with RPL or recurrent implantation failure could have underlying genetic abnormalities in sperm DNA that can be identified. There are a couple of diagnostic tests that we recommend in the evaluation of these men, the first being DNA Fragmentation Index (DFI) and the second, fluorescence in situ hybridization (FISH) for evaluating sperm aneuploidy.

DNA fragmentation occurs due to abnormal packaging of sperm chromatin. Unlike somatic cells that utilize histones as the primary packaging of chromatin, sperm utilize protamines. First, approximately 85% of histones are replaced by protamines, tightly winding chromatin into structures called toroids [2]. In the epididymis, protamines are further compacted by disulfide bond cross-linking. Sperm becomes susceptible to damage if packing with protamines is incomplete. In particular, there are no repair mechanisms that occur once sperm are transported to the epididymis or post ejaculation [3]. High DNA damage as demonstrated by increased DFI is associated with recurrent pregnancy loss, recurrent IVF failure, and increased congenital abnormalities [4,5]. Therefore, men with abnormally elevated DFI can undergo testicular biopsy for sperm retrieval and use with intracytoplasmic sperm injection (ICSI) because DFI in testicular sperm is significantly lower compared to DFI in ejaculated sperm [6]. There are several DFI assays available, and each has its own set of advantages and disadvantages. The sperm chromatin structure assay (SCSA) is commercially available, but the Terminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling (TUNEL) assay, Halo test, and Comet assay are other options.

The second test that can be utilized in men with RPL is sperm aneuploidy testing. Sperm aneuploidy is defined as any deviation from the normal haploid state of sperm. Because many chromosomal aberrations are not viable, clinical testing of sperm aneuploidy has centered on those compatible with survival, namely trisomy 13, 18, 21, X monosomy and Klinefelter (XXY-XXXXY) [7]. The main cause of aneuploidy is nondisjunction, but anaphase lag and ineffective checkpoint control can also contribute to abnormal numbers of chromosomes. Sperm FISH is a cytogenic assay that measures the frequency of chromosomal abnormalities by measuring sperm aneuploidy. FISH can be effective in identifying abnormal sperm aneuploidy in men with RPL and normal sperm parameters. Up to 40% of men with RPL and normal semen parameters had abnormal aneuploidy with FISH [8,9]. Our recommendation for men with increased sperm aneuploidy is to pursue IVF with preimplantation genetic screening (PGS) or early fetal DNA testing in maternal blood.

Taken together, both DFI and FISH testing are recommended in the work-up of male factor in couples with recurrent pregnancy loss or recurrent IVF failure. Men with increased DFI in ejaculated sperm may be counseled for a testicular biopsy in combination with ICSI, and those with increased sperm aneuploidy can be advised to undergo IVF combined with PGS.

Conflict of Interest: The authors have no potential conflicts of interest to disclose.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 11995
  • [From(publication date):
    September-2015 - May 21, 2018]
  • Breakdown by view type
  • HTML page views : 8173
  • PDF downloads : 3822
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7